MKI67 and neoplasm: Indeed, the doxorubicin chemotherapy combined with PL-1/miR-9 nanoparticles markedly augmented the anti-tumor effects of doxorubicin on reducing Ki-67-positive proliferating cells and increasing TUNEL-positive apoptotic cells (Figure 6F-G).